Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paulo Antonio Oldani Félix"'
Autor:
Raquel Leao Orfali, Daniel Lorenzini, Aline Bressan, Anber Ancel Tanaka, Ana Maria Mósca de Cerqueira, André da Silva Hirayama, Andréa Machado Coelho Ramos, Carolina Contin Proença, Claudia Marcia de Resende Silva, Cristina Marta Maria Laczynski, Francisca Regina Carneiro, Gleison Duarte, Gunter Hans Filho, Heitor de Sá Gonçalves, Ligia Pessoa de Melo, Luna Azulay-Abulafia, Magda Blessmann Weber, Maria Cecília Rivitti-Machado, Mariana Colombini Zaniboni, Marília Ogawa, Mario Cezar Pires, Mayra Ianhez, Paulo Antonio Oldani Felix, Renan Bonamigo, Roberto Takaoka, Rosana Lazzarini, Silmara Cestari, Silvia Assumpção Soutto Mayor, Tania Cestari, Zilda Najjar Prado de Oliveira, Phyllis I. Spuls, Louise A.A. Gerbens, Valeria Aoki
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 98, Iss 6, Pp 814-836 (2023)
Abstract This publication is an update of the “Consensus on the therapeutic management of atopic dermatitis - Brazilian Society of Dermatology” published in 2019, considering the novel, targeted-oriented systemic therapies for atopic dermatitis.
Externí odkaz:
https://doaj.org/article/3a0f393d013246a082f54c36dc57253e
Autor:
Paulo Antônio Oldani Felix, Ana Luisa Sampaio, Bruno Leonardo Silva, Analia Luiza Porto Viana
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Patients with psoriasis often have comorbidities and are at increased risk of developing several complications compared with the general population. Knowledge on the role of immune mediators and systemic inflammation in psoriasis has led to the hypot
Externí odkaz:
https://doaj.org/article/7c76828c48584339922e2cda5fa864de
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 92, Iss 5 suppl 1, Pp 85-87 (2017)
Abstract The use of TNF-α inhibitors for the treatment of moderate to severe psoriasis and psoriatic arthritis is increasingly more frequent. The authors report a case of Guillain-Barré syndrome as a late manifestation of the treatment with adalimu
Externí odkaz:
https://doaj.org/article/ffd144821c0c47e99f72bdee01cf95bc
Autor:
Karina de Almeida Pinto Fernandes, Kely Hernández Galvis, Anndressa Camillo da Matta Setubal Gomes, Osvania Maris Nogueira, Paulo Antônio Oldani Felix, Thiago Jeunon de Sousa Vargas
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 91, Iss 5 suppl 1, Pp 32-34 (2016)
Abstract Childhood linear immunoglobulin A dermatosis is a rare autoimmune vesiculobullous disease. It results in linear deposition of autoantibodies (immunoglobulin A) against antigens in the basal membrane zone, leading to subepidermal cleavage. Ad
Externí odkaz:
https://doaj.org/article/2f97776b4a0042399debc126cb11c784
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 90, Iss 5, Pp 728-730 (2015)
AbstractTaxanes are drugs used to treat many types of cancer, including breast and lung cancer. The most common side effects of these drugs are neutropenia and mucositis. Signs of skin toxicity are observed in about 65% of cases and include alopecia,
Externí odkaz:
https://doaj.org/article/02d115e84b5d4dc1bb96875b4865a319
Autor:
Marcelo Arnone, Maria Denise Fonseca Takahashi, André Vicente Esteves de Carvalho, Wanderley Marques Bernardo, Aline Lopes Bressan, Andrea Machado Coelho Ramos, Aripuanã Cobério Terena, Cacilda da Silva Souza, Daniel Holthausen Nunes, Maria Cecília de Carvalho Bortoletto, Maria de Fátima Santos Paim de Oliveira, Jane Marcy Neffá, Luciana Cristina Fieri, Luna Azulay-Abulafia, Paulo Antônio Oldani Felix, Renata Ferreira Magalhaes, Ricardo Romiti, Tatiana Jerez Jaime
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 94, Iss 2 suppl 1, Pp 76-107
Abstract: Psoriasis is a chronic inflammatory disease that affects 1.3% of the Brazilian population. The most common clinical manifestations are erythematous, scaling lesions that affect both genders and can occur on any anatomical site, preferentia
Externí odkaz:
https://doaj.org/article/095fc231bd864a759597d1dd86be36a0
Autor:
Morton Aaron Scheinberg, Paulo Antonio Oldani Felix, Igor Age Kos, Maurício De Angelo Andrade, Valderilio Feijó Azevedo
Publikováno v:
Einstein (São Paulo), Vol 16, Iss 3
ABSTRACT The manufacturing process for biological products is complex, expensive and critical to the final product, with an impact on their efficacy and safety. They have been increasingly used to treat several diseases, and account for approximately
Externí odkaz:
https://doaj.org/article/18433db9d7074770b4239dd425a12ca0